Ajax-Loading

Sanofi SA - Cash and Equivalents

Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.

The item "Cash-and-Equivalents" stands at 8.91 Billion Euros as of 09/30/2025.

As of the end of Sanofi SA's third quarter, the item "Cash and Equivalents" stands at 8.91 Billion EUR. This represents a decrease of -42.01 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.11 Billion Euros compared to the value the year prior.
The 1 year change is 2.11 Billion Euros.
The 3 year change is 15.80 Billion Euros.
The 5 year change is 24.88 Billion Euros.
The 10 year change is 13.83 Billion Euros.

The Serie's long term average value is 1.73 Billion Euros. It's latest available value, on 09/30/2025, is 7.18 Billion Euros higher, compared to it's long term average value.
The Serie's change in Euros from it's minimum value, on 09/30/2020, to it's latest available value, on 09/30/2025, is +24.88 Billion.
The Serie's change in Euros from it's maximum value, on 06/30/2020, to it's latest available value, on 09/30/2025, is -7.06 Billion.

Cash and Equivalents for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash and Equivalents905,699,262,464.00
LogoJohnson & Johnson - Cash and Equivalents486,508,953,600.00
LogoAbbVie Inc - Cash and Equivalents399,570,305,024.00
LogoRoche Holding AG - Cash and Equivalents317,433,206,677.55
LogoAstraZeneca PLC - Cash and Equivalents280,205,508,085.11